Analyst Research Report Snapshot


Allergan, Inc.






04 Aug 2015





Companies referenced:


Available for Immediate Download

Allergan, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Allergan, Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Allergan, Inc. in the form of a SWOT analysis - An in-depth view of the business model of Allergan, Inc. including a breakdown and examination of key business segments - Intelligence on Allergan, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Allergan, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Allergan (or 'the company') is engaged in the discovery, development and commercialization of products addressing ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological and other specialty markets. The company operates primarily in the US, Europe, Asia Pacific and Latin America. The company is headquartered in Irvine, California, and employed approximately 11,400 people as of December 31, 2013. The company recorded revenues of $6,300.4 million during the financial year ended December 2013 (FY2013), an increase of 11.6% over FY2012. The operating profit of the company was $1,809.3 million during FY2013, an increase of 12.3% over FY2012. The net profit was $985.1 million in FY2013, a decrease of 10.3% compared with FY2012. In November 2014, Actavis, an integrated pharmaceutical company, signed a definitive agreement to acquire Allergan for a total transaction value of approximately $66 billion. Reasons to Purchase: - Gain understanding of Allergan, Inc. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Allergan, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Allergan, Inc.’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.